Ardent Health (ARDT) Faces Investor Scrutiny Amid Problems Estimating Collection of Accounts Receivable, Disclosure Drives Stock Down 33% -- Hagens Berman

ARDT Investors with Losses Encouraged to Contact the Firm

SAN FRANCISCO, Nov. 26, 2025 /PRNewswire/ -- On November 13, 2025 investors in healthcare services provider Ardent Health (NYSE: ARDT) saw the price of their shares tumble $4.75 (-33%) after the company announced its Q3 2025 financial results, widely missing consensus EPS estimates and revealing two adverse items characterized as non-recurring.

Read more at prnewswire.com